Clarivate plc (CLVT) announced Tuesday net income for the fourth quarter of $3.1 million or $0.00 per share, compared to a net loss of $191.8 million or $0.27 per share, in the prior-year quarter.
Excluding items, adjusted net income for the quarter was $0.20 per share, compared to $0.21 per share in the year-ago quarter.
Total revenues for the quarter declined to $617.0 million from $663.0 million in the same quarter last year. Revenues were down 1.2 percent on an organic basis.
Looking ahead to fiscal 2026, the company now projects adjusted earnings in a range of $0.70 to $0.80 per share on revenues between $2.30 billion and $2.42 billion.
Following a comprehensive evaluation, the Company also announced it is pursuing a sale of its Life Sciences & Healthcare business. Clarivate has retained Morgan Stanley & Co. LLC as its financial advisor, and is currently engaged in active discussions with interested parties.
In Tuesday's pre-market trading, CLVT is trading on the NYSE at $1.78, up $0.08 or 4.71 percent.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.